期刊文献+

特异识别已分化PC12细胞的ssDNA适体的结构和功能研究 被引量:1

Structure and function of the ssDNA aptamer specifically recognizing differentiated PC12 cells
原文传递
导出
摘要 目的 :研究特异识别已分化PC12细胞的ssDNA适体的二级结构及截短前后的适体与已分化PC12细胞的结合能力。方法 :利用RNAstructure 3.5软件对截短前后的适体的空间结构进行模建 ,体外合成这些截短适体 ,利用流式细胞术和荧光显微镜研究适体与已分化PC12细胞的结合能力。结果 :单茎环结构是适体与已分化PC12细胞结合的二级结构 ;截短后的适体与已分化PC12细胞的结合能力明显大于与未分化PC12细胞结合能力 ;AP17 38与已分化PC12细胞结合的荧光强度明显大于与未分化PC12细胞结合的荧光强度 ;截短前后的适体均能够特异识别混合物中已分化PC12细胞。结论 :截短后的适体能够保留适体的空间结构 ,而且与已分化PC12细胞的亲合力不会降低。 s Objective: To study the structure and function of the ssDNA aptamer specifically recognizing differentiated PC12 cells. Methods RNA structure 3.5 software was used to simulate the steric structure of the aptamer 17 and its truncated form. The flow cytometry and fluorescent microscopy were used to analyze aptamer binding activity to PC12 cells. Results: The single stem-loop structure was the basic structure of the aptamers specifically binding to differentiated PC12 cells; truncated aptamers with this basic structure could specifically bind to differentiated PC12 cells. No binding to undifferentiated PC12 cells was observed using both flow cytometry and fluorescent microscopy. Aptamer 17 and its truncated form could specifically recognize the differentiated PC12 cells from a mixture of various cells. Conclusion: Truncated aptamers showed the similar basic structure and binding ability to aptamer 17.
出处 《军事医学科学院院刊》 CSCD 北大核心 2004年第6期516-518,529,共4页 Bulletin of the Academy of Military Medical Sciences
基金 国家青年"863"高技术基金资助课题
关键词 ssDNA适体 结构 功能 ssDNA aptamers structure function
  • 相关文献

参考文献10

  • 1Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase[J]. Science,1990,249(4968): 505-510.
  • 2Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands[J]. Nature,1990,346(628): 818-822.
  • 3Hicke BJ, Stephens AW. Escort aptamers: a delivery service for diagnosis and therapy [J]. J Clin Invest, 2000,106(8): 923-928.
  • 4White RR, Sullenger BA, Rusconi CP. Developing aptamer into therapeutics[J]. J Clin Invest,2000,106(8): 929-934.
  • 5Gold L. Oligonucleotides as research, diagnostic, and therapeutic agents[J]. J Biol Chem, 1995,270(23): 13581-13584.
  • 6Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics[J]. Clin Chem,1999,45(9): 1628-1650.
  • 7Wang CL,Zhang M, Yang G,et al. Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment[J].J Biotechnol, 2003,102(1): 15-22.
  • 8Gold L, Polisky B, Uhlenbeck O,et al. Diversity of oligonucleotide functions[J]. Annu Rev Biochem,1995,64:763-797.
  • 9王成龙,刘洪臣,邵宁生,王会信.寡核苷酸配基在临床诊断和疾病治疗中的应用[J].国外医学(药学分册),2003,30(4):223-228. 被引量:3
  • 10Famulok M, Szostak JM. Stereospecific recognition of tryptophan agarose by in vitro selected RNA[J]. J Am Chem Soc, 1992,114(10): 3990-3991.

二级参考文献20

  • 1Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase[J].Science,1990,249(4968):505-510
  • 2Ellington AD, Szostak JW. In vitro selectivon of RNA molecules that bind specific ligands[J]. Nature, 1990, 346(6287) :818 - 822.
  • 3Hicke BJ, stephens AW. Escort aptamers:a delivery service for diagnosis and therapy[J]. J Clin Invest, 2000, 106(8):923-928.
  • 4Clark SL,Remcho VT,Aptamers as analytical reagents[J].Electrophoresis,2002, 23(9) : 1335 - 1340.
  • 5Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy:accomplishments and limitaions[J].Curr Cancer Drug Targets,2002,2(4):355-368
  • 6Joshi P, Prasad VR. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX(systematic evolution of ligands by exponential enrichment)[J].J Virol,2002,76(13):6545-6557
  • 7Andreola ML, Pileur F, Calmels C, et al. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity[J].Biochemistry,2001,40(34):10087-10094
  • 8Bock LC, Griffin LC, Latham JA,et al. Selection of single-swanded DNA molecules that bind and inhibit human thrombin[J]. Nature, 1992, 355(6360) :564- 566.
  • 9Rusconi CP,Yeh A,Lyerly HK,et al.Blocking the initiation of coagulation by RNA aptamers to factor Ⅶa[J].Thromb Haemost,2000,84(5):841-848
  • 10Rusconi CP, Scardino E, Layzer J,et al. RNA aptamers as reversible antagonists of coagulation factor Ⅸa[J].Nature,2002,419(6902):90-94

共引文献2

同被引文献8

  • 1[1]Tuerk C,Gold L.Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase[J].Science,1990,249:505-510
  • 2[2]Ellington A D,Szostak,J W.In vitro selection of RNA molecules that bind specific ligands[J].Nature(London),1990,346:818-822
  • 3[3]Clonis YD.Affinity chromatography matures as bioinformatic and combinatorial tools develop[J].J Chromatogr A,2005,1101(1-2):1-24
  • 4[4]Mosing RK,Mendonsa SD,Bowser MT.Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase[J].Anal Chem,2005,77(19):6107-6112
  • 5[7]Stoltenburg R,Reinemann C,Strehlitz B.FluMag-SELEX as an advantageous method for DNA aptamer selection[J].Anal Bioanal Chem,2005,383:83-91
  • 6[9]Wang C,Zhang M,Yang G,et al.Single-stranded DNA aptamers that bind differentiated but not parental ceils:subtractive systematic evolution of ligands by exponential enrichment[J].J Biotechnol,2003,102(1):15-22
  • 7邵宁生.SELEX技术在药物筛选中的应用[J].中国药理学会通讯,2000,17(3):6-7. 被引量:1
  • 8王成龙,刘洪臣,邵宁生,王会信.寡核苷酸配基在临床诊断和疾病治疗中的应用[J].国外医学(药学分册),2003,30(4):223-228. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部